Mackay Shields LLC Veracyte, Inc. Transaction History

Mackay Shields LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$32.94 - $56.62 $876,203 - $1.51 Million	-26,600 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$44.47 - $81.38 $675,944 - $1.24 Million	-15,200 Reduced 36.36%	26,600 $1.43 Million
Q4 2020 Feb 16, 2021	BUY	$32.49 - $61.88 $1.36 Million - $2.59 Million	41,800 New	41,800 $2.05 Million
Q2 2020 Jul 31, 2020	SELL	$19.49 - $28.11 $329,381 - $475,059	-16,900 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$16.13 - $30.17 $272,597 - $509,873	16,900 New	16,900 $410,000

333

76.6M

212K

18.5K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.24B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.